Publications:

Favorable immune checkpoint inhibitor outcome of patients with melanoma and NSCLC harboring FAT1 mutations.

Npj Precision Oncology

Zhang, Wenjing W; Tang, Yunfeng Y; Guo, Yuxian Y; Kong, Yujia Y; Shi, Fuyan F; Sheng, Chao C; Wang, Suzhen S; Wang, Qinghua Q

Publication Date: 2022-06-23

Variant appearance in text: FAT1: P4495L

PubMed Link: 35739249

Variant Present in the following documents:

• 41698_2022_292_MOESM1_ESM.xlsx, sheet 1

View BVdb publication page

Integrated molecular drivers coordinate biological and clinical states in melanoma.

Nature Genetics

Conway, Jake R JR; Dietlein, Felix F; Taylor-Weiner, Amaro A; AlDubayan, Saud S; Vokes, Natalie N; Keenan, Tanya T; Reardon, Brendan B; He, Meng Xiao MX; Margolis, Claire A CA; Weirather, Jason L JL; Haq, Rizwan R; Schilling, Bastian B; Stephen Hodi, F F; Schadendorf, Dirk D; Liu, David D; Van Allen, Eliezer M EM

Publication Date: 2020-12

Variant appearance in text: FAT1: 13484C>T; P4495L

PubMed Link: 33230298

Variant Present in the following documents:

• NIHMS1637640-supplement-SuppData1.xlsx, sheet 1

View BVdb publication page